- IBDEI3AT ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.4,59,0)
- ;;=PROCEDURE CODES^3^12
- ;;^UTILITY(U,$J,358.4,60,0)
- ;;=FAMILY TRAINING-GROUP^2^12
- ;;^UTILITY(U,$J,358.4,61,0)
- ;;=RECREATION THERAPY DX^1^13
- ;;^UTILITY(U,$J,358.4,62,0)
- ;;=1-1 THERAPEUTIC PROCEDURES^1^14
- ;;^UTILITY(U,$J,358.4,63,0)
- ;;=EDUCATION/TRAINING^3^14
- ;;^UTILITY(U,$J,358.4,64,0)
- ;;=TEAM CONFERENCE^6^14
- ;;^UTILITY(U,$J,358.4,65,0)
- ;;=ASSESSMENT^2^14
- ;;^UTILITY(U,$J,358.4,66,0)
- ;;=FAMILY TRAINING^4^14
- ;;^UTILITY(U,$J,358.4,67,0)
- ;;=SPECIALTY PROCEDURES-INDIVIDUAL^5^14
- ;;^UTILITY(U,$J,358.4,68,0)
- ;;=RECREATION THERAPY DX^1^15
- ;;^UTILITY(U,$J,358.4,69,0)
- ;;=RESPIRATORY^10^16
- ;;^UTILITY(U,$J,358.4,70,0)
- ;;=SLEEP TESTING AND EVAL^11^16
- ;;^UTILITY(U,$J,358.4,71,0)
- ;;=PULMONARY FUNCTION TESTS^9^16
- ;;^UTILITY(U,$J,358.4,72,0)
- ;;=ABG/OX/TRANSCUTANEUOUS^1^16
- ;;^UTILITY(U,$J,358.4,73,0)
- ;;=HOME OXYGEN CLINIC^6^16
- ;;^UTILITY(U,$J,358.4,74,0)
- ;;=CPAP^2^16
- ;;^UTILITY(U,$J,358.4,75,0)
- ;;=EDUCATION/TRAINING^3^16
- ;;^UTILITY(U,$J,358.4,76,0)
- ;;=PROLONGED CLINICAL STAFF SERVICES^8^16
- ;;^UTILITY(U,$J,358.4,77,0)
- ;;=HOME SLEEP STUDIES^7^16
- ;;^UTILITY(U,$J,358.4,78,0)
- ;;=TELEHEALTH PATIENT SITE^12^16
- ;;^UTILITY(U,$J,358.4,79,0)
- ;;=NEW PATIENT^2^17
- ;;^UTILITY(U,$J,358.4,80,0)
- ;;=ESTABLISHED PATIENT^1^17
- ;;^UTILITY(U,$J,358.4,81,0)
- ;;=CONSULTATIONS^3^17
- ;;^UTILITY(U,$J,358.4,82,0)
- ;;=PULMONARY DIAGNOSES^2^18
- ;;^UTILITY(U,$J,358.4,83,0)
- ;;=SLEEP DX PRELIMINARY^3^18
- ;;^UTILITY(U,$J,358.4,84,0)
- ;;=SLEEP DX CONFIRMED^4^18
- ;;^UTILITY(U,$J,358.4,85,0)
- ;;=OTHER SLEEP RELATED DX^6^18
- ;;^UTILITY(U,$J,358.4,86,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^5^18
- ;;^UTILITY(U,$J,358.4,87,0)
- ;;=OBESITY & BMI DX^1^18
- ;;^UTILITY(U,$J,358.4,88,0)
- ;;=SPECIAL SERVICES^6^19
- ;;^UTILITY(U,$J,358.4,89,0)
- ;;=TREATMENT^7^19
- ;;^UTILITY(U,$J,358.4,90,0)
- ;;=MISCELLANEOUS^4^19
- ;;^UTILITY(U,$J,358.4,91,0)
- ;;=IMMUNIZATIONS^3^19
- ;;^UTILITY(U,$J,358.4,92,0)
- ;;=CHEMO ADMINISTRATION^1^19
- ;;^UTILITY(U,$J,358.4,93,0)
- ;;=CHEMO DRUGS^2^19
- ;;^UTILITY(U,$J,358.4,94,0)
- ;;=OTHER DRUGS^5^19
- ;;^UTILITY(U,$J,358.4,95,0)
- ;;=NEW PATIENT^2^20
- ;;^UTILITY(U,$J,358.4,96,0)
- ;;=ESTABLISHED PATIENT^1^20
- ;;^UTILITY(U,$J,358.4,97,0)
- ;;=CONSULTATIONS^3^20
- ;;^UTILITY(U,$J,358.4,98,0)
- ;;=POST OP^4^20
- ;;^UTILITY(U,$J,358.4,99,0)
- ;;=ANEMIA^2^21
- ;;^UTILITY(U,$J,358.4,100,0)
- ;;=BREAST & GYN NEOPLASMS^2^21
- ;;^UTILITY(U,$J,358.4,101,0)
- ;;=COAGULATION DISORDERS^3^21
- ;;^UTILITY(U,$J,358.4,102,0)
- ;;=COUNSELING & SCREENING^4^21
- ;;^UTILITY(U,$J,358.4,103,0)
- ;;=GENITOURINARY NEOPLASMS^5^21
- ;;^UTILITY(U,$J,358.4,104,0)
- ;;=GI CANCER^6^21
- ;;^UTILITY(U,$J,358.4,105,0)
- ;;=HEAD/NECK/LUNG CANCER^7^21
- ;;^UTILITY(U,$J,358.4,106,0)
- ;;=HEMOGLOBINOPATHIES^9^21
- ;;^UTILITY(U,$J,358.4,107,0)
- ;;=LYMPHOID NEOPLASMS^10^21
- ;;^UTILITY(U,$J,358.4,108,0)
- ;;=METASTATIC SITES^11^21
- ;;^UTILITY(U,$J,358.4,109,0)
- ;;=MISC. NEOPLASMS^12^21
- ;;^UTILITY(U,$J,358.4,110,0)
- ;;=MYELOID NEOPLASMS/DISORDERS^13^21
- ;;^UTILITY(U,$J,358.4,111,0)
- ;;=PERSONAL HX OF CANCER^15^21
- ;;^UTILITY(U,$J,358.4,112,0)
- ;;=OTHER^14^21
- ;;^UTILITY(U,$J,358.4,113,0)
- ;;=HEMATOLOGICAL^8^21
- ;;^UTILITY(U,$J,358.4,114,0)
- ;;=SYMPTOMS^17^21
- ;;^UTILITY(U,$J,358.4,115,0)
- ;;=TREATMENT^18^21
- ;;^UTILITY(U,$J,358.4,116,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^16^21
- ;;^UTILITY(U,$J,358.4,117,0)
- ;;=ABNORMAL LAB TEST RESULTS^1^21
- ;;^UTILITY(U,$J,358.4,118,0)
- ;;=SPECIAL SERVICES^10^22
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3AT 3782 printed Feb 19, 2025@00:11:35 Page 2
- IBDEI3AT ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.4)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.4,59,0)
- +2 ;;=PROCEDURE CODES^3^12
- +3 ;;^UTILITY(U,$J,358.4,60,0)
- +4 ;;=FAMILY TRAINING-GROUP^2^12
- +5 ;;^UTILITY(U,$J,358.4,61,0)
- +6 ;;=RECREATION THERAPY DX^1^13
- +7 ;;^UTILITY(U,$J,358.4,62,0)
- +8 ;;=1-1 THERAPEUTIC PROCEDURES^1^14
- +9 ;;^UTILITY(U,$J,358.4,63,0)
- +10 ;;=EDUCATION/TRAINING^3^14
- +11 ;;^UTILITY(U,$J,358.4,64,0)
- +12 ;;=TEAM CONFERENCE^6^14
- +13 ;;^UTILITY(U,$J,358.4,65,0)
- +14 ;;=ASSESSMENT^2^14
- +15 ;;^UTILITY(U,$J,358.4,66,0)
- +16 ;;=FAMILY TRAINING^4^14
- +17 ;;^UTILITY(U,$J,358.4,67,0)
- +18 ;;=SPECIALTY PROCEDURES-INDIVIDUAL^5^14
- +19 ;;^UTILITY(U,$J,358.4,68,0)
- +20 ;;=RECREATION THERAPY DX^1^15
- +21 ;;^UTILITY(U,$J,358.4,69,0)
- +22 ;;=RESPIRATORY^10^16
- +23 ;;^UTILITY(U,$J,358.4,70,0)
- +24 ;;=SLEEP TESTING AND EVAL^11^16
- +25 ;;^UTILITY(U,$J,358.4,71,0)
- +26 ;;=PULMONARY FUNCTION TESTS^9^16
- +27 ;;^UTILITY(U,$J,358.4,72,0)
- +28 ;;=ABG/OX/TRANSCUTANEUOUS^1^16
- +29 ;;^UTILITY(U,$J,358.4,73,0)
- +30 ;;=HOME OXYGEN CLINIC^6^16
- +31 ;;^UTILITY(U,$J,358.4,74,0)
- +32 ;;=CPAP^2^16
- +33 ;;^UTILITY(U,$J,358.4,75,0)
- +34 ;;=EDUCATION/TRAINING^3^16
- +35 ;;^UTILITY(U,$J,358.4,76,0)
- +36 ;;=PROLONGED CLINICAL STAFF SERVICES^8^16
- +37 ;;^UTILITY(U,$J,358.4,77,0)
- +38 ;;=HOME SLEEP STUDIES^7^16
- +39 ;;^UTILITY(U,$J,358.4,78,0)
- +40 ;;=TELEHEALTH PATIENT SITE^12^16
- +41 ;;^UTILITY(U,$J,358.4,79,0)
- +42 ;;=NEW PATIENT^2^17
- +43 ;;^UTILITY(U,$J,358.4,80,0)
- +44 ;;=ESTABLISHED PATIENT^1^17
- +45 ;;^UTILITY(U,$J,358.4,81,0)
- +46 ;;=CONSULTATIONS^3^17
- +47 ;;^UTILITY(U,$J,358.4,82,0)
- +48 ;;=PULMONARY DIAGNOSES^2^18
- +49 ;;^UTILITY(U,$J,358.4,83,0)
- +50 ;;=SLEEP DX PRELIMINARY^3^18
- +51 ;;^UTILITY(U,$J,358.4,84,0)
- +52 ;;=SLEEP DX CONFIRMED^4^18
- +53 ;;^UTILITY(U,$J,358.4,85,0)
- +54 ;;=OTHER SLEEP RELATED DX^6^18
- +55 ;;^UTILITY(U,$J,358.4,86,0)
- +56 ;;=SUICIDE IDEATIONS/ATTEMPTS^5^18
- +57 ;;^UTILITY(U,$J,358.4,87,0)
- +58 ;;=OBESITY & BMI DX^1^18
- +59 ;;^UTILITY(U,$J,358.4,88,0)
- +60 ;;=SPECIAL SERVICES^6^19
- +61 ;;^UTILITY(U,$J,358.4,89,0)
- +62 ;;=TREATMENT^7^19
- +63 ;;^UTILITY(U,$J,358.4,90,0)
- +64 ;;=MISCELLANEOUS^4^19
- +65 ;;^UTILITY(U,$J,358.4,91,0)
- +66 ;;=IMMUNIZATIONS^3^19
- +67 ;;^UTILITY(U,$J,358.4,92,0)
- +68 ;;=CHEMO ADMINISTRATION^1^19
- +69 ;;^UTILITY(U,$J,358.4,93,0)
- +70 ;;=CHEMO DRUGS^2^19
- +71 ;;^UTILITY(U,$J,358.4,94,0)
- +72 ;;=OTHER DRUGS^5^19
- +73 ;;^UTILITY(U,$J,358.4,95,0)
- +74 ;;=NEW PATIENT^2^20
- +75 ;;^UTILITY(U,$J,358.4,96,0)
- +76 ;;=ESTABLISHED PATIENT^1^20
- +77 ;;^UTILITY(U,$J,358.4,97,0)
- +78 ;;=CONSULTATIONS^3^20
- +79 ;;^UTILITY(U,$J,358.4,98,0)
- +80 ;;=POST OP^4^20
- +81 ;;^UTILITY(U,$J,358.4,99,0)
- +82 ;;=ANEMIA^2^21
- +83 ;;^UTILITY(U,$J,358.4,100,0)
- +84 ;;=BREAST & GYN NEOPLASMS^2^21
- +85 ;;^UTILITY(U,$J,358.4,101,0)
- +86 ;;=COAGULATION DISORDERS^3^21
- +87 ;;^UTILITY(U,$J,358.4,102,0)
- +88 ;;=COUNSELING & SCREENING^4^21
- +89 ;;^UTILITY(U,$J,358.4,103,0)
- +90 ;;=GENITOURINARY NEOPLASMS^5^21
- +91 ;;^UTILITY(U,$J,358.4,104,0)
- +92 ;;=GI CANCER^6^21
- +93 ;;^UTILITY(U,$J,358.4,105,0)
- +94 ;;=HEAD/NECK/LUNG CANCER^7^21
- +95 ;;^UTILITY(U,$J,358.4,106,0)
- +96 ;;=HEMOGLOBINOPATHIES^9^21
- +97 ;;^UTILITY(U,$J,358.4,107,0)
- +98 ;;=LYMPHOID NEOPLASMS^10^21
- +99 ;;^UTILITY(U,$J,358.4,108,0)
- +100 ;;=METASTATIC SITES^11^21
- +101 ;;^UTILITY(U,$J,358.4,109,0)
- +102 ;;=MISC. NEOPLASMS^12^21
- +103 ;;^UTILITY(U,$J,358.4,110,0)
- +104 ;;=MYELOID NEOPLASMS/DISORDERS^13^21
- +105 ;;^UTILITY(U,$J,358.4,111,0)
- +106 ;;=PERSONAL HX OF CANCER^15^21
- +107 ;;^UTILITY(U,$J,358.4,112,0)
- +108 ;;=OTHER^14^21
- +109 ;;^UTILITY(U,$J,358.4,113,0)
- +110 ;;=HEMATOLOGICAL^8^21
- +111 ;;^UTILITY(U,$J,358.4,114,0)
- +112 ;;=SYMPTOMS^17^21
- +113 ;;^UTILITY(U,$J,358.4,115,0)
- +114 ;;=TREATMENT^18^21
- +115 ;;^UTILITY(U,$J,358.4,116,0)
- +116 ;;=SUICIDE IDEATIONS/ATTEMPTS^16^21
- +117 ;;^UTILITY(U,$J,358.4,117,0)
- +118 ;;=ABNORMAL LAB TEST RESULTS^1^21
- +119 ;;^UTILITY(U,$J,358.4,118,0)
- +120 ;;=SPECIAL SERVICES^10^22